Monday, June 15, 2026

Nelson’s Last Stand: How the Battle of Trafalgar Shaped Europe’s Future

On October 21, 1805, a significant naval battle took place off the southwestern coast of Spain near Cape Trafalgar.

How North Korea’s Recent Missile Test Challenges Global Security: A Detailed Analysis

North Korea's missile launch is condemned by South Korea's National Security Office, emphasizing the need for immediate cessation of provocations.

“Targeting U.S. defense market with ‘Poniard’”…LIG D&A participates in SAS 2026

LIG D&A showcases advanced defense solutions at SAS 2026, targeting the U.S. market with guided rockets and unmanned vehicles.

Jung Eun Kim

Author's Latest

Samsung Bioepis Launches AI Academy: How 1,000 Employees Will Master AI by July 2026

Samsung Bioepis launches an AI training program for employees to enhance skills in biopharmaceuticals, boosting global competitiveness.

How Dr. Ville is Revolutionizing Medical Knowledge Sharing for 40,000+ Doctors in 2026

Dr. Ville expands as a physician platform, offering relevant content and support, surpassing 40,000 members with significant growth in engagement.

Samchundang Pharma CEO Claims FDA Recognition for Obesity Drug as Generic

Samchundang Pharma's CEO announces FDA recognition of oral semaglutide as a generic and withdraws $1.7 billion stock sale plan.

Osstem Implant Highlights Global Influence Through International Academic Event

Osstem Implant's "World Meeting 2026" showcased digital dentistry advancements with 1,200 global attendees, celebrating 10 years of innovation.

Revolutionary Biodegradable Stents for Pets: Meet the First Four Approved by South Korea

M.I. Tech has become the first South Korean company to receive approval for biodegradable stents for pets, addressing traditional stent complications.

Revolutionizing Stroke Treatment: How AI is Transforming Care at Korea University Anam Hospital

JLK's stroke AI solution is enhancing clinical efficiency at Korea University Anam Hospital through rapid imaging and data-driven decisions.

AI in Healthcare: AITRICS-VC Gains Approval in Indonesia – What This Means for Patients

AITRICS gains approval for its AI solution VitalCare in Indonesia, aiding early prediction of patient condition deterioration.

SK Biopharmaceuticals Unveils Breakthrough Findings on NTSR1-Targeted Radiopharmaceutical SKL35501

SK Biopharmaceuticals will present findings on NTSR1-targeted treatments at the AACR Annual Meeting, showcasing innovative oncology research.

How Hanmi’s Dual Inhibitor HM97662 is Revolutionizing Cancer Treatment: Key Insights from AACR 2026

Hanmi Pharmaceutical to present nine groundbreaking cancer research studies at AACR 2026, showcasing innovative therapies and AI-driven analytics.

SK Biopharmaceuticals Selects Two CNS Startups Through Open Innovation… Advances Expected in Parkinson’s and Alzheimer’s Treatment

SK Biopharmaceuticals partners with Seoul Bio Hub to support two CNS startups, Novorex and Threebrooks, in innovative drug development.

Discover the First-Ever 5-in-1 Calcium and Vitamin D Supplement: What You Need to Know About ‘Adtaminjeong’

Bukwang Pharmaceutical launches Edtamin Tablet, a supplement with calcium and vitamins to support nerve function and fetal development.

Hugel Partners with Hansbiomed: What Does the New ECM Product CellREDM Mean for Your Skin?

Hugel partners with HansBiomed to distribute CellREDM, enhancing skin regeneration and expanding its product portfolio in medical aesthetics.

Exploring Cenobamate: How SK Biopharmaceuticals’ New Oral Suspension Benefits Adult Epilepsy Patients

SK Biopharmaceuticals submits NDA for Cenobamate oral suspension, enhancing treatment options for epilepsy patients with swallowing difficulties.

South Korea Government Response: Quick Solutions to Naphtha Supply Issues for Medical Materials

South Korea's government is expediting approvals for medical supply production amid naphtha supply issues, easing industry concerns.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.